Extreme Hypofractionation for Newly Diagnosed Glioblastoma: Rationale, Dose, Techniques, and Outcomes

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{d2117696d3ac4b5e8f5b35fd2eb50618,

title = "Extreme Hypofractionation for Newly Diagnosed Glioblastoma: Rationale, Dose, Techniques, and Outcomes",

author = "Rupesh Kotecha and Minesh Mehta",

note = "Neuro-Oncology (2020) 22(8):1062-1064",

year = "2020",

month = aug,

day = "17",

language = "American English",

volume = "22",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - Extreme Hypofractionation for Newly Diagnosed Glioblastoma: Rationale, Dose, Techniques, and Outcomes

AU - Kotecha, Rupesh

AU - Mehta, Minesh

N1 - Neuro-Oncology (2020) 22(8):1062-1064

PY - 2020/8/17

Y1 - 2020/8/17

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3510

M3 - Article

VL - 22

JO - Neuro-oncology

JF - Neuro-oncology

ER -